A world where a robot quickly scans your body for skin cancer or your forehead lines stay frozen with just a treatment or two ...
Aesthetic advancements across Galderma’s portfolio Galderma will also present the latest data from across its Injectable Aesthetics portfolio, including updates on Restylane, Sculptra ...
Shareholders of Galderma, the Swiss maker of skincare products including botox, launched a block trade on Monday night to ...
The Asia Pacific aesthetic medicine market is poised for exponential growth, with its valuation expected to rise from US$ 21.47 billion in 2024 to US$ 65.42 billion by 2033, registering a Compound ...
With a projected market value of USD 71.49 billion by 2033, the U.S. aesthetic medicine industry is on a remarkable growth trajectory. The increasing adoption of innovative cosmetic procedures, ...
Before Letybo was approved, there were five neuromodulators available to injectors in the US: Botox, Xeomin, Dysport, Daxxify ...
The Differin owner’s mini-games are aimed at addressing acne's emotional impact on Gen Z and Gen Alpha consumers ...
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year ...
The hyaluronic acid products market in Brazil is poised for remarkable growth, projected to exceed USD 485.8 billion by 2025 and reach an impressive USD 740.4 billion by 2035, expanding at a CAGR of 4 ...
Swiss skincare company Galderma will talk to major American retailers about trade tariffs imposed by the U.S. government in ...
Galderma convenes a new edition of the Galderma Aesthetic Injector Network (GAIN) event in the Asia-Pacific region (JPAC), which will be the largest to date, bringing together more ...
The global dermal fillers market share analysis is poised for significant growth, with total sales projected to reach USD 6,466.6 million by 2025. This surge is fueled by the increasing demand for non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results